Lazard Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $63K | Buy |
|
|||||
|
2024
Q4 | $27K | Hold |
|
|||||
|
2024
Q3 | $20K | Buy |
|
|||||
|
2024
Q2 | $25K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $909K | Buy |
|
|||||
|
2022
Q3 | $559K | Buy |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $261K | Buy |
|
|||||
|
2021
Q4 | $181K | Sell |
|
|||||
|
2021
Q3 | $2.04M | Buy |
|
|||||
|
2021
Q2 | $571K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $875K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $118K | Sell |
|
|||||
|
2015
Q1 | $2.43M | Buy |
|
|||||
|
2014
Q4 | $8K | Buy |
|